Incidence of retinopathy of prematurity treatment in extremely preterm infants in China

Yi Dai, Li Zhu, Yequn Zhou, Yanqiu Wu, Dongmei Chen, Ruiquan Wang, Linlin Wu, Shaoqing Guo, Lingling Gao, Ping Xu, Yang Wang, Shanshan Dong, Ning Liu, Haoming Chen, Yumei Sun, Chao Chen, Shulian ZhangPaediatric 2021 · DOI

Abstract

The incidence of EP infants receiving ROP treatment showed no change during this 10-year period in China. Prevention of prematurity and foetal growth restriction, judicious use of oxygen and reducing comorbidities are promising factors that may reduce the incidence of ROP needing treatment in these high-risk infants.
BibTeX
@inproceedings{dai2021incidence,
  author = {Yi Dai and Li Zhu and Yequn Zhou and Yanqiu Wu and Dongmei Chen and Ruiquan Wang and Linlin Wu and Shaoqing Guo and Lingling Gao and Ping Xu and Yang Wang and Shanshan Dong and Ning Liu and Yan Wu and Haoming Chen and Yumei Sun and Chao Chen and Shulian Zhang},
  title = {{Incidence of retinopathy of prematurity treatment in extremely preterm infants in China}},
  booktitle = {Paediatric},
  year = {2021},
  doi = {10.1111/ppe.12810},
}

Loading related content...

Figure